Sirius XM Holdings Inc. (SIRI) traded within a range of $4.69 to $4.74 after opening the day at $4.71. The company has seen its stock increase in value by 6.52% so far this year. The stock was up close to 0.42% on light volume in last trading session and closed at $4.73 per share. After the recent gain, the stock is currently holding -1.66% below its 52 week high of $4.82 and 43.12% above its 12-month low of $3.42. The shares are up by over 10.49% in the last three months, and the RSI indicator value of 59.08 is neither bullish nor bearish, tempting investors to stay on the sidelines.
Sirius XM Holdings Inc. provides satellite radio services in the United States. The company broadcasts music plus sports, entertainment, comedy, talk, news, traffic, and weather programs, including various music genres ranging from rock, pop and hip-hop to country, dance, jazz, Latin, and classical; live play-by-play sports from principal leagues and colleges; multitude of talk and entertainment channels for various audiences; national, international, and financial news; and limited run channels. It also streams music and non-music channels over the Internet; and offer applications to allow consumers to access its Internet radio service on smartphones, tablets, computers, home devices, and other consumer electronic equipment. In addition, the company distributes satellite radios through the sale and lease of new vehicles; and acquires subscribers through the sale and lease of previously owned vehicles with factory-installed satellite radios. Its satellite radio systems include satellites, terrestrial repeaters, and other satellite facilities; studios; and radios. Further, the company provides satellite television services, which offer music channels on the DISH NETWORK satellite television service as a programming package; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedule and scores, and movie listings; real-time traffic services; and real-time weather services. Additionally, it offers location-based services through two-way wireless connectivity, including safety, security, convenience, maintenance and data services, remote vehicles diagnostics, and stolen or parked vehicle locator services. The company also sells satellite radios directly to consumers through its Website, as well as through national and regional retailers. The company was founded in 1990 and is headquartered in New York, New York. Sirius XM Holdings Inc. is a subsidiary of Liberty Media Corporation.
Regions Financial Corporation (RF) managed to rebound with the stock declining 0% or $0 to close the day at $14.99 on light trading volume of 17.5M shares, compared to its three month average trading volume of 21.13M. The Birmingham Alabama 35203 based company has been outperforming the regional – southeast banks group over the past 52 weeks, with the stock gaining 117.14%, compared to the industry which has advanced 69.74% over the same period. With RSI of 61.49, the stock should still continue to rise and get closer to its one year target estimate of $15.23, making it a hold for now.
Regions Financial Corporation, together with its subsidiaries, provides banking and bank-related services to individual and corporate customers in the United States. Its Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending, as well as equipment lease financing services. This segment serves corporate, middle market, small business, and commercial real estate developers and investors. The company’s Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, small business loans, indirect loans, consumer credit cards, and other consumer loans, as well as the corresponding deposit relationships. Its Wealth Management segment offers wealth management products and services, including credit related products, trust and investment management, asset management, retirement and savings solutions, estate planning, and personal and commercial insurance products to individuals, businesses, governmental institutions, and non-profit entities. The company also provides insurance coverage for various lines of personal and commercial insurance, such as property, vehicle, casualty, life, health, and accident insurance, as well as commercial crop, life, and environmental insurance; and commercial equipment financing products, as well as offers securities, insurance, and advisory services through financial consultants. In addition, it offers securities brokerage, merger and acquisition advisory, trust, and other specialty financing services. As of December 31, 2015, the company operated 1,627 banking offices and 1,962 ATMs in Alabama, Arkansas, Florida, Georgia, Illinois, Indiana, Iowa, Kentucky, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee, Texas, and Virginia. Regions Financial Corporation was founded in 1971 and is headquartered in Birmingham, Alabama.
Gilead Sciences Inc. (GILD) gained $0.77 to close the day at a new closing price of $66.36, a 1.17% increase in value from its previous closing price that moved the stock 1.5% above its 52 week low of $65.38. A total of 16.19M shares exchanged hands during the day compared with its three month average trading volume of 10.32M. The stock, which fluctuated between $65.43 and $66.78 during the day, currently situated -34.46% below its 52 week high. The stock is down by -10.04% in the past one month and down by -14.89% over the past three months. With a one year target estimate of $84.27 and RSI of 30.92, the stock still has upside potential, making it a hold for now.
Gilead Sciences Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. The company’s products include Genvoya, Stribild, Complera/Eviplera, Atripla, Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread, and Hepsera products for the treatment of liver diseases. It also offers Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the treatment of certain blood cancers; Letairis, an endothelin receptor antagonist for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging; Cayston, an inhaled antibiotic for the treatment of respiratory systems in cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the treatment and prevention of influenza A and B. In addition, the company provides other products, such as AmBisome, an antifungal agent to treat serious invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to treat neovascular age-related macular degeneration. Further, it has product candidates in various stages of development for the treatment of HIV/AIDS and liver diseases, such as hepatitis B virus and hepatitis C virus; inflammation/oncology; serious cardiovascular; and respiratory conditions, as well as diabetic nephropathy and ebola. The company markets its products through its commercial teams and/or in conjunction with third-party distributors and corporate partners. Gilead Sciences Inc. has collaboration agreements with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc., and Galapagos NV. The company was founded in 1987 and is headquartered in Foster City, California.